Oncology Generics Medicines
Estimated value
—
Awarded value
—
Suppliers
69
Lots
35
Published
05 Feb 2021
Description
This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in section II.2 of this notice.
Scope
- Reference
- NP39720
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Logistics | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 35 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 35 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Lot 1 Bendamustine Powder For Solution For Infusion | — | cancelled |
| 2 | Lot 2 Capecitabine Tablets | — | cancelled |
| 3 | Lot 3 Carboplatin Injection | — | cancelled |
| 4 | Lot 4 Cisplatin Injection | — | cancelled |
| 5 | Lot 5 Cyclophosphamide Injection, Powder For Reconstitution | — | cancelled |
Award 1· 1 supplier
Awarded —
Award 2· 1 supplier
Awarded —
Award 3· 1 supplier
Awarded —
Award 4· 1 supplier
Awarded —
Award 5· 1 supplier
Awarded —
Award 6· 1 supplier
Awarded —
Award 7· 1 supplier
Awarded —
Award 8· 1 supplier
Awarded —
Award 9· 7 suppliers
Awarded —
Award 10· 3 suppliers
Awarded —
Award 11· 1 supplier
Awarded —
Award 12· 1 supplier
Awarded —
Award 13· 1 supplier
Awarded —
Award 14· 1 supplier
Awarded —
Award 15· 1 supplier
Awarded —
Award 16· 1 supplier
Awarded —
Award 17· 1 supplier
Awarded —
Award 18· 1 supplier
Awarded —
Award 19· 1 supplier
Awarded —
Award 20· 1 supplier
Awarded —
Award 21· 1 supplier
Awarded —
Award 22· 1 supplier
Awarded —
Award 23· 1 supplier
Awarded —
Award 24· 1 supplier
Awarded —
Award 25· 1 supplier
Awarded —
Award 26· 1 supplier
Awarded —
Award 27· 2 suppliers
Awarded —
Award 28· 2 suppliers
Awarded —
Award 29· 3 suppliers
Awarded —
Award 30· 1 supplier
Awarded —
Award 31· 1 supplier
Awarded —
Award 32· 1 supplier
Awarded —
Award 33· 1 supplier
Awarded —
Award 34· 23 suppliers
Awarded —
Award 35· 1 supplier
Awarded —
Total lots
35
Awarded
35
Estimated total
—
Awarded total
—
Lot 1 Bendamustine Powder For Solution For Infusion
Start
—
End
—
Estimated
—
CPV
Lot 2 Capecitabine Tablets
Start
—
End
—
Estimated
—
CPV
Lot 3 Carboplatin Injection
Start
—
End
—
Estimated
—
CPV
Lot 4 Cisplatin Injection
Start
—
End
—
Estimated
—
CPV
Lot 5 Cyclophosphamide Injection, Powder For Reconstitution
Start
—
End
—
Estimated
—
CPV
Lot 6 Cytarabine Injections
Start
—
End
—
Estimated
—
CPV
Lot 7 Dacarbazine Injections
Start
—
End
—
Estimated
—
CPV
Lot 8 Disodium Folinate Injection
Start
—
End
—
Estimated
—
CPV
Lot 9 Docetaxel Concentrate For Solution For Infusion
Start
—
End
—
Estimated
—
CPV
Lot 10 Doxorubicin Hydrochloride Injections
Start
—
End
—
Estimated
—
CPV
Lot 12 Etoposide Injection
Start
—
End
—
Estimated
—
CPV
Lot 13 Fluorouracil 25MG/ML Injection
Start
—
End
—
Estimated
—
CPV
Lot 14 Fluorouracil 50MG/ML Injection
Start
—
End
—
Estimated
—
CPV
Lot 15 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials
Start
—
End
—
Estimated
—
CPV
Lot 16 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials
Start
—
End
—
Estimated
—
CPV
Lot 18 Idarubicin Hydrochlioride Injection Powder For Reconstitution
Start
—
End
—
Estimated
—
CPV
Lot 19 Ifosfamide Injection Powder For Reconstitution
Start
—
End
—
Estimated
—
CPV
Lot 20 Irinotecan Hydrochloride Injection
Start
—
End
—
Estimated
—
CPV
Lot 21 Lanreotide Injection Prefilled Syringes
Start
—
End
—
Estimated
—
CPV
Lot 22 Methotrexate Without Preservatives Injection
Start
—
End
—
Estimated
—
CPV
Lot 23 Methotrexate Oral Solution
Start
—
End
—
Estimated
—
CPV
Lot 25 Oxaliplatin Vial Solution
Start
—
End
—
Estimated
—
CPV
Lot 26 Paclitaxel Concentrate For Intravenous Infusion
Start
—
End
—
Estimated
—
CPV
Lot 27 Temozolomide Capsules
Start
—
End
—
Estimated
—
CPV
Lot 28 Vincristine Without Preservatives Injection
Start
—
End
—
Estimated
—
CPV
Lot 29 Vinorelbine Injection
Start
—
End
—
Estimated
—
CPV
Lot 30 Octreotide Vials Long Acting (Excluding Homecare)
Start
—
End
—
Estimated
—
CPV
Lot 31 Octreotide Vials Long Acting (Including Homecare)
Start
—
End
—
Estimated
—
CPV
Lot 33 PEGFILGRASTIM 6MG PRE-FILLED SYRINGE
Start
—
End
—
Estimated
—
CPV
Lot 34 APREPITANT CAPSULES
Start
—
End
—
Estimated
—
CPV
Lot 37 OCTREOTIDE INJECTION
Start
—
End
—
Estimated
—
CPV
Lot 36 TOPOTECAN CONCENTRATE FOR SOLUTION FOR INFUSION
Start
—
End
—
Estimated
—
CPV
Lot 38 Filgrastim Pre-Filled Syringe
Start
—
End
—
Estimated
—
CPV
Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
Start
—
End
—
Estimated
—
CPV
Lot 11 Imatinib
Start
—
End
—
Estimated
—
CPV
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Waverley Pharma Europe Limited· 7
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS National Generic Pharmaceuticals Wave 14b | contract | — | 10 Aug 2023 |
| NHS National Generic Pharmaceuticals Wave 14b | contract | — | 10 Aug 2023 |
| NHS National Generic Pharmaceuticals Wave 14a | contract | £2.1m | 18 Jan 2023 |
| NHS National Generic Pharmaceuticals Wave 14a | contract | — | 18 Jan 2023 |
| NHS National Generic Pharmaceuticals Wave 13 | contract | — | 14 Jan 2022 |
| NHS National Generic Pharmaceuticals - Transition 2021_2 | contract | £163k | 07 Jun 2021 |
| NHS national Generic Pharmaceuticals Transition 2021_2 | contract | — | 04 Jun 2021 |